ASP Isotopes (ASPI) News Today

Vanguard Group Inc. increased its holdings in ASP Isotopes Inc. (NASDAQ:ASPI - Free Report) by 479.1% during the first quarter, according to its most recent disclosure with the SEC. The institutional investor owned 1,021,019 shares of the company's stock after buying an additional 844,705 shares d

ASP Isotopes Inc. (NASDAQ:ASPI - Get Free Report) was the target of a significant increase in short interest during the month of July. As of July 31st, there was short interest totalling 6,730,000 shares, an increase of 23.0% from the July 15th total of 5,470,000 shares. Approximately 19.1% of the company's stock are sold short. Based on an average trading volume of 1,120,000 shares, the days-to-cover ratio is currently 6.0 days.

ASP Isotopes Inc. (NASDAQ:ASPI - Free Report) - Equities researchers at HC Wainwright lowered their FY2024 EPS estimates for ASP Isotopes in a research note issued to investors on Wednesday, August 7th. HC Wainwright analyst H. Ihle now forecasts that the company will earn ($0.24) per share for t

HC Wainwright cut their target price on shares of ASP Isotopes from $5.50 to $4.50 and set a "buy" rating for the company in a research note on Wednesday.

ASP Isotopes Inc. (NASDAQ:ASPI - Get Free Report) was the target of a large increase in short interest during the month of June. As of June 30th, there was short interest totalling 2,840,000 shares, an increase of 86.8% from the June 15th total of 1,520,000 shares. Based on an average trading volume of 947,200 shares, the short-interest ratio is currently 3.0 days. Currently, 10.3% of the company's stock are short sold.

ASP Isotopes Inc. (NASDAQ:ASPI - Get Free Report) major shareholder Ak Jensen Investment Managemen acquired 61,849 shares of the firm's stock in a transaction on Wednesday, July 10th. The shares were acquired at an average price of $3.40 per share, with a total value of $210,286.60. Following the completion of the purchase, the insider now owns 6,678,723 shares of the company's stock, valued at $22,707,658.20. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Major shareholders that own at least 10% of a company's stock are required to disclose their transactions with the SEC.

ASP Isotopes (NASDAQ:ASPI) Trading 1.7% Higher

ASP Isotopes Inc. (NASDAQ:ASPI - Get Free Report) Director Robert John Andrew Ryan purchased 4,313 shares of the company's stock in a transaction dated Monday, April 29th. The stock was purchased at an average price of $3.20 per share, for a total transaction of $13,801.60. Following the transaction, the director now directly owns 555,868 shares in the company, valued at approximately $1,778,777.60. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link.

ASP Isotopes Inc. (NASDAQ:ASPI - Get Free Report) Director Robert John Andrew Ryan acquired 9,500 shares of the business's stock in a transaction dated Thursday, April 25th. The shares were purchased at an average price of $3.42 per share, with a total value of $32,490.00. Following the transaction, the director now owns 546,555 shares of the company's stock, valued at $1,869,218.10. The acquisition was disclosed in a document filed with the SEC, which is available at the SEC website.

ASP Isotopes Inc. (NASDAQ:ASPI - Get Free Report) saw a large increase in short interest in the month of April. As of April 15th, there was short interest totalling 722,000 shares, an increase of 52.1% from the March 31st total of 474,600 shares. Approximately 3.2% of the company's stock are sold short. Based on an average daily trading volume, of 638,000 shares, the short-interest ratio is presently 1.1 days.

ASP Isotopes Inc. (NASDAQ:ASPI - Free Report) - Research analysts at HC Wainwright lowered their FY2024 EPS estimates for ASP Isotopes in a report released on Wednesday, April 17th. HC Wainwright analyst H. Ihle now expects that the company will post earnings of ($0.11) per share for the year, do

ASP Isotopes Inc. (NASDAQ:ASPI - Free Report) - Investment analysts at HC Wainwright issued their FY2025 EPS estimates for ASP Isotopes in a research note issued to investors on Wednesday, April 17th. HC Wainwright analyst H. Ihle expects that the company will post earnings per share of ($0.07) f

HC Wainwright raised their price objective on shares of ASP Isotopes from $5.25 to $5.50 and gave the stock a "buy" rating in a report on Wednesday.

ASP Isotopes Inc. (NASDAQ:ASPI - Get Free Report) saw a significant increase in short interest in the month of March. As of March 15th, there was short interest totalling 277,300 shares, an increase of 15.0% from the February 29th total of 241,100 shares. Approximately 1.2% of the shares of the company are short sold. Based on an average daily trading volume, of 484,800 shares, the days-to-cover ratio is currently 0.6 days.

ASP Isotopes Inc. (NASDAQ:ASPI - Get Free Report) saw a large increase in short interest in February. As of February 29th, there was short interest totalling 241,100 shares, an increase of 216.0% from the February 14th total of 76,300 shares. Based on an average daily volume of 409,900 shares, the short-interest ratio is presently 0.6 days. Currently, 1.1% of the company's stock are sold short.

ASP Isotopes Inc. (NASDAQ:ASPI - Get Free Report) saw a significant decrease in short interest in February. As of February 15th, there was short interest totalling 76,300 shares, a decrease of 54.7% from the January 31st total of 168,600 shares. Based on an average daily trading volume, of 399,400 shares, the short-interest ratio is currently 0.2 days. Approximately 0.3% of the company's shares are sold short.

ASP Isotopes Inc. (NASDAQ:ASPI - Get Free Report) Director Robert John Andrew Ryan purchased 15,596 shares of the business's stock in a transaction on Monday, January 29th. The stock was acquired at an average price of $2.35 per share, for a total transaction of $36,650.60. Following the completion of the purchase, the director now owns 537,055 shares of the company's stock, valued at $1,262,079.25. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink.